The Ideal Anxiolytic
1987; Slack Incorporated (United States); Volume: 17; Issue: 3 Linguagem: Inglês
10.3928/0048-5713-19870301-07
ISSN1938-2456
AutoresSamuel Gershon, Arlene S. Eison,
Tópico(s)Eicosanoids and Hypertension Pharmacology
ResumoAdvances in PsychopharmacologyThe Ideal Anxiolytic Samuel Gershon, MD, , and , MD Arlene S Eison, MA, , MA Samuel Gershon, MD and Arlene S Eison, MA Psychiatric Annals, 2013;17(3):156–170Published Online:March 01, 1987https://doi.org/10.3928/0048-5713-19870301-07View Full TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Rosenhauni IF: The drug lreaimeni of anxteiy. N Engl J Med 1982: 306:401-404. Google Scholar2. Dennis JL, Hendrie MC: Treaimem of anxiety stales: Sume theoretical and practical aspects.. / Indiana State Mai Assoc 1980: Mav: 300-305. Google Scholar3. Werkman SL: The clinical spectrum of anxiety. Psychiatric Annals 1981; 11(Suppl):7-8. Google Scholar4. Denber HCB: Anxiolytics. neuroleptics and other drugs in the treatment of anxiety. Am J Psychother 1982; 36:304-317. Google Scholar5. Rickets K: Useofantianxietyagenis in anxious outpaiients. Psychopharmacology 1978; 58:1-17. Google Scholar6. Harvey SC: Hypnotics and sedatives, in Oilman AG, Goodman LS. Oilman A (eds): Pharmacological liasis of Therapeutics, ed 6. New York, MacMillan Publishing Co. 1980, pp 319-375. Google Scholar7. Baldessarini RJ: Drugs and the treatment of psychiatric disorders, in Oilman Au. Goodman LS, Oilman A (eds): Pharmacological liasis of Therapeutics, ed 6. New York. Macmillan Publishing Co, 1980. pp 191-447. Google Scholar8. Edwards |G: Adverse effects of anlianxiety drugs. Drugs 1981; 22:495-514. Google Scholar9. Tallman fF, Paul SM, Skolnick P, et al; Receptors for t he age of anxiety: Pharmacology of the benzodiazepines. Science 1980: 207:274-281. Google Scholar10. Rickels K : Benzodiazepines in the treatment of anxiety. Am J Psychotherapy (982; 36:358-370. Google Scholar11. BraestrupC.NeilsenM: Anxiety. Lancet 1982; ii:1030-1034. Google Scholar12. BellantuonoC.Reggi V. Tognoni G. etal: Benzodiazepines: Clinical pharmacology and therapeutic use. Drug!, 1980; 19:195-219. Google Scholar13. Ascione FJ: Benzodiazepines and alcohol. Drug Therapy 1978; 9:58-71. Google Scholar14. Greenblatl DJ. Shader RI: Benzodiazepines in Medical Practice. New York. Raven Press. 1974. Google Scholar15. Marks J: The Benzvdiazepines: Use. Overuse. Misuse. Abuse. London, MTP Press, 1978. Google Scholar16. Tompkins EC. demento Aj. Taylor DP. et al: Inhibition of aggressive behavior in rhesus monkeys by huspirone. Research Communications in Psychology. Psychiatry, and Behavior 1980: 5:337-351. Google Scholar17. Cook L. Sepinwall J; Behavioral analysis of tht effects of benzodiazepines. in Costa E, Greengard P (eds): Mechanisms of Action of Benzodtazepines. New York. Raven Press. 1975. 18. Bracslrup C, Squirts Rf-": Brain specific benzodiazcpine receptors. Kr J Psychiatry 1978; 133:249-260. Google Scholar19. Costa E. Guidoni A. Mao CC. et al: New concepts on the mechanism of action of benzodiazepines. Life Sci 1975; 17:167-186. Google Scholar20. Young Ali, Snyder SH: Strychnine binding associated with glycine receptors of the central nervous system. Prut- Nal AcadSci USA 1973; 70:2832-2836. Google Scholar21. Wise CD. Berger BD. Stein L: Evidence of alpha noradrcnergic reward receptors and serotonergic punishment receptors in the ral brain. Hint Psychiatry 1473; 6:3-21. Google Scholar22. Patel (B, Malick JH: Pharmacological properties of tracazolate: A new nonbenzodiazepine anxiotylic agent, Eur J Pharmacoi 1982; 79:323-333. Google Scholar23. Meiners BA, Salama AI: Enhancement of benzodiazepine and GABA binding by the novel anxiolytic. tracazotate. Eur J Pharmacol 1982; 78;315-322. Google Scholar24. Sakalis C, Sathananlhan G, Collins P, et al: SO 65396: A non-sedative anxiolytic? Curr Ther Res 1974; 16:861. Google Scholar25. Beer B. Chasin M. Clody DE. et al: Cyclic adenosine monophosphale phos phodiest e rase in brain. Effect on anxieiy. Science 1972; 176:428-430. Google Scholar2b. Psychoyos S, Ford CJ. Phillipps MA: Inhibition by etazolaie (SQ 20009) and cariazolate ISO 65396) of adenosine-slimulatcd PH! cAMP forma lion in 2-[^sup 3^H) adenine-prelabeled vesicles prepared from guinea pig cerebral cortex. Hiochem Pharmacol 1982; 31:1441-1442. Google Scholar27. McNeil Pharmaceuticals: Pharmacological profile of McN 3377-98, a potential anti-anxiety agent. Pharmacological Report No. 256 (740125) M cNeil International Report. January 25, 1974. Google Scholar28. Rastogi RG, Lapierre YD. Singhal Rl,: Some behavioral and neuropharmacological aspects of fenobam: A new antianxiety drug. Recent Advances in Canadian Neuropsychopharmacology 1980; 2:26-35. Google Scholar29. Lapierre YD, Oyewumi LK; Fenobam: Another anxiolytic? Curr Ther Res 1982; 31:95-101. Google Scholar30. Pecknold JC, McClure DJ, Appeltauer L. et al: Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study. Clin Psychopharmacol 1982; 2:129-133. Google Scholar31. LeFurG. Mizoule J. Burgcwn MC, et al: Multiple benzodiazepine receptors: Evidence of a dissociation between anticonflict and antieonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives!. Life Sci 1981; 28:1439-1448. Google Scholar32. Gee KW, Yamamura HI: A novel pyrazoloquinoline that interacts with brain benzodiazepine receptors: Characterization of some in vitro and in vivo properties of CGS 9896. Life Sci 1982; 30:2245-2252. Google Scholar33. Yokoyama N, Olenn T; COS 9896 and CGS 8216: Potent benzodiazepine receptor agonist and antagonist. 184lh ACN National Meeting Abstracts. Division of Medicinal Chemistry. Abstract 58. 1982. Google Scholar34. Clineschmidt BV. Williams M. Witoslawski II, et al: Restoration ol shock-suppressed behavior by treatment with ( + )-5-methyl-IO, ll-dihydro-5H-dibenzo Ia. d| cyclohepien, - 5.10-imine I M K-KOl). a substance with potent aniiconvulsant . central sympathomimetic and apparent anxiolytic properlies. Drug Development Research 1982; 2:147-163 Google Scholar35. Kffland RC. Forsch MF: Anti-anxiety agents, anticonvulsants and sedative hypnotics. Annual Reports in Medicina! Chemistry 1982; 17:11-19. Google Scholar36. Olivier B: Selective antiaggressive properties of DU 27725: Ethological analyses of intermale and territorial aggression in the male rat. Pharmacol Biochem Behav 1981; 14(Suppl 1):61-77. Google Scholar37. van der Poel AM. Olivier B, Mos J. et al: Antiaggressive effect of a new phenylpip-erazicie compound (DU 27716) un hypolhalamicallyinduced behavioral activities. Pharmacol Hiochem Behav 1982; 17:147-153. Google Scholar38. Molander L: Effect of melperom;. chlorprarnazine, haloperidol and diazepam on experimental anxieiy in normal subjects. Psychopharmacology 1982; 77:109-113. Google Scholar39. Aflen LE, Ferguson HC. Cox RIi fr: Pharmacologie effects of MJ 9022-1, a potential tranquiiizing agent. Arzneimittel-Forschung 1974; 24:917-922. Google Scholar40. Riblet LA. Taylor DP. Elson MS, et al: Pharmacology and neurochemistry of buspirone. J Clin Psychiatry 1982; 43(12. Sec 21:11-16. Google Scholar4 1 . Gelier J, Hartman RJ: Effects of buspirone on operant behavior of laboratory rats and cynomologus monkeys. J Clin Psychiatry 1 982 ; 43(12. Sec 21:25-32. Google Scholar42. McMillen BA. Matthews RT. Sanghera MK. et al: Dopamine receptor antagonism by the novel antianxiely drug, buspirone. J Neurvsci 1983; 3:733 758. Google Scholar43. Balster RL, Woolverton WL; Intravenous buspirone self-administration in rhesus monkeys. J Clin Psychiatry 1982; 43112. Sec 2):34-37. Google Scholar44. Alien HL: Physical dependence study using buspirone and diazepam in rats. Mead Johnson Research Center. Biological Research Report No. 8094, 1980. Google Scholar45. Goldherg HL, Finnerty RJ: The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry 1979; 136:1184-1187. Google Scholar46. Goldberg HL. Finnerty Rf: Comparison of buspirone in two separate studies. J Clin Psychiatry 1982:43(12. Sec 2):87-91. Google Scholar47. Rickels K: Recent advances in anxiolytic therapy. J Clin Psychiatry 1981; 42(Sec 2):40-44. Google Scholar48. Rickels K, Weisman K. Norslad N. ei al: Buspirone and diazepam in anxiety: A controlled study. J ClinPsychiatry 1982; 43(12. Sec 21:81-86. Google Scholar49. Feighner JP, Merideth CH,Hendrickson GA: A double-blind comparison of buspirone and diazepum in outpatients with generalized anxiety disorder. J Clin Psychiatry 1982: 43(12. Sec 21:103-107. Google Scholar50. Newton RE. Casten GP, A Jim DR, et al. The side effect profile of buspirone in comparison to active controls and placebo. J Clin Psychiatry 1982; 43(12, Sec 21:100-102. Google Scholar5 1 . Lader M: Psychological effects of buspirone. J Clin Psychiatry 1982; 43(12. Sec 21:62-67. Google Scholar52. Moskowitz H. Smiley A: Effects of chronically administered buspirone and diazepam on driving-refaicd skills performance. J Clin Psychiatry 1982: 43(12, Sec 21:45-55. Google Scholar53. Mattila MJ, Aranko K. Seppala T: Acute effects of buspirone and alcohol on psychomolor skills. J Clin Psychiatry 1982; 43(12, Sec 21:56-60. Google Scholar54. Gershon S: Drug interactions in controlled clinical trials. J Clin Psychiatry 1982; 43(12. Sec 21:95-98. Google Scholar55. Cole JO, Orzack MH. Beake B. el al: Assessment of the abuse liability of buspirone in recreational sedative users. J Clin Psychiatry 1982; 43(12. Sec 21:59-74. Google Scholar56. Squires RF. Braeslrup C: Renzodiazepine receptors in rat brain. Nature 1977; 266:732-734. Google Scholar57. Guidoni A, Baraldi M. Leon A. el al: Benzodiazepines: A tool to explore the biochemical and neurophysiological basis of anxiety. Fed Proc 1980; 39:3039-3042. Google Scholar58. BraestrupC. NielsenH: Bt-nzodiazepine receptors. Arsneimittel-Furschung 1980; 30:852-857. Google Scholar59. Mohk-r H, OkiiJa T: Proper! ies of 1Hdiazcpam binding to benzodiazepine receptors in rat cerebral cortex. Life Sci 1977; 20:2101-2110. Google Scholar60. Mohler H. Okada T, Heitz PH. et al. Biochemical identification ol the site of action of benzodiazepines in human brain by ^sup 3^H-diazepam binding. Life Sci 1978; 22:985-496. Google Scholar61. Yamamura HI, Enna Sl. Kuhar MJ: Neurotransmilter Receptor Rinding. New York, Raven Press, 1978. Google Scholar62. Lippa AS. Klepner CA. Yunger L. et al: Relationship between benzodiazepine receptors and experimental anxiety in rats. Pharmacol Biochem Behav 1978; 9:853-856. Google Scholar63. Speth RC. Wasiek G). fohnson PC. L-t al: Benzodiazepine binding in human brain: Characterization using ^sup 3^H-flunitrazepam. Life Sci 1977; 22:732-734. Google Scholar64. Lippa AS. Sano MC. Coupet I. et al: Evidence that benzodiazepine receptors reside on cerebellar Purkinje cells: Studies with "nervous mutant mice." Life Sci 1978; 23:2213-2218. Google Scholar65. Mohler H. Bailersy MK, Richards IG: Benzodiazepine receptor protein identified and visualized in brain [issue by a phoio-aflinity label. PTOC Nal Acad Sci USA 1980; 77:1666-1670. Google Scholar66. Kuhar MJ: The benzudiazepine receptor anatomical aspects. NIDA Research Monograph 1980: 35:12-21. Google Scholar67. Gray JA: The Neuropsychology of Anxiety. New York. Oxford Univcrsiiy Press. 1982. Google Scholar68. Young WS III, NiehofT D, Kuhar M], el al: MuUiptt benzodiazcpine receptor localization by light microscopic radiohisiochemistry. / Pharmcol Exp Ther 1981; 216:425-430. Google Scholar69. Schmitl Rr, Vogel ME, Zimrnermann M: Die Wirkung von Diazepam aufdie prusynaplische Henrmung und andere Ruckennarkefiexe: Naunyn Schmiedebergs Arch Phartnok Exp Path 1967: 258:69-82. Google Scholar70. Haefly W, Kulscai A. MohlerH.et al; Possible involvemetil of C ABA in lhe central actions ut ihe benzodìazepines, in Costa E, Greengard R (ed;.): Mechanisms of Action of Renzodiazep'tnes. New York, Raven Press. 1975, pp 131-153. Google Scholar71. Haefly W, Pole P. Schaffner R. et al; Facilitation of GABAergic transmission by drugs, in Krogsgaard-Larsen P, Scheel -Kruger J Kofod H (eds): G AB A- N eurotransmitiers. Copenhagen, Munksgaard, 1979. pp 357-375. Google Scholar72. Lippa AS. Nash PA. Greenblatl EN: Preelinical neuropsychopharmacological procedures lor anxiolytic drugs, in Fielding S, Lai H ledi.); Anxiolytics. New York. Futura Publishing Co, 1979. pp4l-8!. Google Scholar73. Olsen RW: Drug interactions at the GABA receptor- i onophore complex. Aim u Rev I'hartnticol 1982: 22:245-277. Google Scholar74. Burch TD, Ticku MK; Ethanol enhances [^sup 3^H]diazepam binding at the benzodiazepine GABA-receplor-ionophore complex, Eur / Pharmacol 1980: 67:525-326. Google Scholar75. Paul SM. Marangos I'LSkolnickP: Thcbcnzodiazepini: GABA-ch!oride ionophore receptor complex: Common site of minor tranquilizer action. Bio/ Psychiatry 1981; 16:213-229. Google Scholar76. Guidoni A. Toffano G, Costa f,: An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in the rat brain. Nature 1978; 275:514-516. Google Scholar77. LaI H, Shearman GT, Fielding S. el al; Evidente that GARA mechanisms mediate the anxiolytic action of benzodiazepines: A study with valproic acid. Nfurapharmacology 1980: 19:785-789. Google Scholar78. Soubrie P. Thiebot MH. Simon P: Enhanced suppressive effects of a ver si ve events induced in rats by picTotoxin: Possibility of a GABA control on behavioral inhibilion. Pharmacol Biochem liehai· 1979; 10:463-469. Google Scholar79. HuotS, Robin M. Palfreyman MG: Effect of 2V'inyl GAHA alone or associated with diazepam on a conflict lest in the rat. in DeFeudis FV. Mandel P (eds): Amino Acid Neurotrunstnitien. New York. Raven Press, 1981. pp 45-52. Google Scholar80. Scheel-Kriiger J. Petersen EN: Amiconflicf effect of the benzodiazepines mediated by GABAergic mechanism in (he amygdala. Eur / Phannacoi 1982; 82:M5-!I6. Google Scholar81. Roberls E: Status and perspective, in Krogsgaard-Larsen P. Scheel-Kruger |. Kofod H (eds): GABA- Neurotransmitters. New York. Academic Press. 1979. pp 533-545. Google Scholar82. Aznilia EC, Segal M: Auloradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. / Comp Mt'urol 1978: 179:641-65!. Google Scholar83. Dahlstrom A, Fuxe K: Evidence for the existence of monoa mine-containing neurons in the central nervous system, Ada Phvsiol Scanii 1964: b2lSuppi 2321:1-55. Google Scholar84. FuyeK-lohnsonG: Further mapping of central 5- hydroxytryptamine neurons: Studies with the neuroloxic dihydroxytryptamines. Adv Riochcm Phannacoi 1974; 10:1-12. Google Scholar85. Geller I. Blum K: The effects of 5-HTP on parachlorciphenylalanine (p-CPA) attenuation of "conflict" behavior. Kur / Pharmacoi 1970; 9:319-324. Google Scholar86. Tye NC, [versen SD, Green AR: The effect of benzudiazepincsatvisetaUmeirgic manipulations on punished responding, Neuropharmacoiogy 1979; 18:689-696. Google Scholar87. Tye NC, Eventi B|, !versen SC: 5-hydroxytryptamine and punishment. Nature 1977; 268:741-742. Google Scholar88. Geller I, Hartmann Rl.Croy DJ: Attenuation of conflict with cinanserin, a serotonin antagonist Reversa! of the effect with 5-hydroxylryptophan and 2-meihyll rypiamine, Res Commun C'hem Pathoi Phannacoi 1974; 7:165-174. Google Scholar89. Sepinwall 1, Cook L: Relationships of ≶raminyhiityric acid (GABA) to amianxiety effects of benzodiazepines. Rrain Res Bull 1980; 5:839-848. Google Scholar90. Gracff FG, Schoenfeld RI: Tryptaminergic mechanisms in punished and nonpunished behavior. / Pharmacoi Exp Ther 1970; 173:277-283. Google Scholar91. Graeff FG: Minor tranquilizers and brain defense systems. Brazilian I Med ???? Res 1981: 14:239-265. Google Scholar92. Kilts CD. Commissarii RL, Cordon II. et al: Lack of central 5-hydroxytryptamine influence on the aniiconflicl activity of diazeparn. Psychopharmacology 1982; 78:156-164. Google Scholar93. Stein L. Wise CD. Berger BD: Antianxiety action of henzodiazepines - Decrease in activity of serotonin neurons in ihe punishment system, in Garaltini S, Mussini F, Randall LO (etlsV. The Kenzoditizepines. New York. Raven Press. 1973, pp 229-326. Google Scholar94. Wise CD. Berger BD, Stein L: Benzodiazepines: Anxiety- reducing activity by reduction of serotonin turnover in [he brain. Science 1972; 177:180-183. Google Scholar95. Gallager DW: Benzodiazepines poienlialion of a GABA inhibitory response in the dorsal raphe nucleus, Eur I Pharmacoi 1978: 49:133-143, Google Scholar96. Trukon. ME. Preussler DW. Howell GA. et al: Raphe unit activity in freely moving cats: Effects of benzodiazepines. Neuropharmucofafy 1982; 21:1045-1050. Google Scholar97. Thieboi MH, Hamon M, Soubrie IJ: Attenuation of induced-anxiety in rats by chlordiuzepoxide: Role of raphe dorsalis benzodiazepine binding sites and seroioncrgic neurons. Neuroscience 1982; 7i9);2287-2294. Google Scholar98. Peroulka SJ. SnyderSH: PHI-Mianserin; Differential labeling of serolonin, and histamine. receptors in rat brain. / Pharmacoi Exp Ther 1981: 216:142-148. Google Scholar99. Vargaflig Hit. Coignet ]L, DeVos C[. et al: Mianserin hydrochloride; Peripheral and central effects in relations to antagonism against 5hydroxylryptamineand lryptamine. Eur/ Pharmacoi 1971; 16:556-346.' Google Scholar100. Murphy IE; Mianst'rin in the treatment of depressive illness and anxiety states in general practice. HrI Clin Phunnacut 1978; 5(suppl I); 81-85. Google Scholar101. Ulogur S, Grunhaus L. Bij-macher B. el al; Treatment uf spontaneous panic attacks with clomipramine. Am / Pt,vchiairy 1981; 138:1215-1217. Google Scholar102. Evans L.. Best J. Moure G, el al: Zimt'lidine: A serotonin uptake block in the treatment of phobic anxiety. Prog Neurupsychopharmacal 1980: 4:75-79. Google Scholar103. Persyko I: Psychiatric adverse reaction to niethysergide, / Nerv Ment Dis 1972; 154:299-301. Google Scholar104. Hoehn-Saric R: Neurotransm itiers in anxiety. Arch Gen Psychiatry 1982: 39:735-742. Google Scholar105. Lindvall O, Bjorklund A: Organization of catecholamine neurons in the rat central nervous system, in !versen LL, !versen SC, Snyder SH leds): Handbook of Psychopharmacology. New York. Plenum Press, 1978, pp 139-231. vol. 9 Google Scholar106. Rcdmond DE Jr: New and old evidence for the involvement of a brain norepinephrine system in anxieiv. in Fenn WE led): The Phenomenology and Treatment of Anxiety. New York. Spectrum. 1979, pp 153-203. Google Scholar107. Barchas [P. Freedman DX: Brain amines: Response lo physiological stress. Hiochem Pharmacal 1963: 12:1225, Google Scholar108. Redmond DE Jr. Huang YH: New evidence for a locus coeruleus-norepinephrinc conneclion with anxiety- Ufe Sii 1979; 25:2149-2162. Google Scholar109. Redmond DE IT. Huang YH. Sivyder DR, et al: Behavioral effects of stimulation of the nucleus locus coeruleus in the sturnp-tailcd monkey Macaca arctoides. Brain Res 1976: 116:502-510. Google Scholar110. Granist, Huang YH. Redmond DE Jr: Benzodiazepines attenuate single unit activity in (he locus eoenileus. Li/e Sa 1980; 27:2231-2236. Google Scholar111. Sanghcra MK, McMillen BA. German DC: Buspirone, a non-benzodiazepine anxiolylic, increases locus coeruleus noradrcnergic neuronal activity. Ear I Pharmucol 1983; 86:197-210. Google Scholar112. Mason ST, H biger HC: Anxiety: The locus coeruleus disconnection. Life Sd 1979; 25:2141-2147. Google Scholar113. Cook L, Davidson AB: Effects of behaviorally active drugs in a conflict-punishment procedure in rats, in Garaltini S, Mussini F. Randall LD (eds); The Betizodiazepines, New York. Raven Press. 1973. pp 327-Î45. Google Scholar114. SvenssonTH, Persson R, Wallin L, et al: Anxiolytic action of clonidine. NORD Psykiatr T 1975; 32:439-441. Google Scholar115. Hoehn-Saric R. Merchant AJ. Keyser ML. el al: Effects of clonidine on anxiety disorders. Arch Gen Psychiatry 1981; 38:1278-1282. Google Scholar116. Liebowitz MR, Fyer A|. McCrath P, e! al: Clonidine treatment of panic disorder. Psychopharmacol Bull 1981; 17:122-123. Google Scholar117. Gold MS. Redmond DE, Kleber HD: Clonidine blocks acute opiate withdrawal symptoms. Lancet 1978; 2:599-602. Google Scholar118. Uhde TW. Post RM, Siever L, et al: Clonidine: Effects on mood, anxiety, and pain. Psycfiopharmacol Hull 1981; 17:122-123. Google Scholar119. Hokfelt B. Hcdeland H. Dymling J-F: Studies on catee hol a m i n es, renin and aldosterone following Calapresan (2-2,6-dichlorphcnylamine-2-imidazoline hydrochloride) in hypertensive patients. Eur / Pharmacoi 1970; 10:387-389. Google Scholar120. Corrodi 11, Fuxe K, Libfrink P, el al: Minor tranquilizers. stress, and central catechoiamine neurons. Brain Res 1971; 29:1-16. Google Scholar121. Taylor DP, Riblel LA. Stanlon HC, et al: Dopamine and antianxiely activity. Pharmacoi Biothem Rehav 1982; 17 (suppl ]):25-35. Google Scholar122. Rickcls K: Antineurotic agents: Specific and non-specific effects, in Ef ron DH, Cole |O, Levine |. el al (eds): Psychopharmacology: A Review of Progress 1957-1967. 231-247. Public Health Service Publication No. 1856, 1968, pp 231-247. Google Scholar123. Gray JA: "The neuropsychology of anxiety. Br J Pachol 1978: 69:417-434. Google Scholar124. Gray JA: The behavioral inhibition system: a possible substrate for anxiety, in Fcldman MP, Broadhursl A feds): Theoretical and Experimental liases uf the Behavior Therapies, London, Wiley. 197b. pp Google Scholar125. Gray JA: Drug effects on fear and frustration: Pussible limbic site ul action of minor tranquilizers, in !versen LL. Iversen SD. Snyder SI I ledi.): Handbook of Psychopharmacology. New York. Plenum Press. 1977. pp 433-529; vol 8. Google Scholar126. McNaughlon N. Mason ST: The ogy und neuropharmacology of the dorsal ascending noradrenergic bundle - ? review. Prog Neurobiol 1980: 14:157-219. Google Scholar127. Gray IA. Ball GG: Frequency-specilic between hippocampal theta rhythm, behavior and amobarbital action. Science 1970; 168:1246-1248. Google Scholar128. Gray I A. McNaughlon N. lames DTD. et Effect of minor tranquilizers on hippocampal theta rhythm mimicked by depleiion of forebrain noradrenaline. Nature 1975; 258:424425. Google Scholar129. Braeslrup C. Nielsen M. Olsen CE: Urinary brain ß-carboline-5-carboxylates as potent inhibitors of brain benzodiazepine receptors. ProcNut Acuti Sci USA 1980; 77:2288-2292. Google Scholar130. Tenen SS. Hirsch JD: ßcarboline-3-carboxylic acid ethyl ester antagonizes diazepan activity Nature 1980; 288:609-610. Google Scholar131. Cowen PI. Green AR. Null DT. et al: Ethyl ßcarboline carboxylate lowers seizure threshold and antagonizes llurazepam-induced in rats. Nature 1981; 290:54-55. Google Scholar132. Ninan PT. Insel TM. Cohen RM. et al: Benzodiazepine receptor-mediated "anxiety" in primates. Science 1982: 218:1352-1534. Google Scholar133. Dorow R: ß-earboline monomcihylamide causes anxiety in man. 1 5th Collegium Internationale Neuro-psychopharmaeologium gress, lerusalem. |une 20-25, 1982. abstract I. Google Scholar134. Tanaka T. Starke K: Antagonisl/agonist-preferring αadrenoceptors or α1/α2 adrenoceptors? Eur J Pharmacol 1980; 65:191-194. Google Scholar135. Starke K: Regulation of noradrenaline release by presynaptic receptors systems. Rev Physiol Biochem Pharmacol 1977;" 77:1-124. Google Scholar136. Guerreo-Figueroa R, Gallant DM. Galatas RF, et al: Effects of yohimbine on CNS structures: Neurophysiological and behavioral correlations. Psych o pharm a co logia 25:155-145. Google Scholar137. Lang W|. Gershon S: Effects oí psychoactive drugs on yohimbine-induced responses in conscious dogs; A proposed screening for cedure lor anti-anxiety agents. Arch Im I'harmucodyn Titer 19b5; 142:456-472. Google Scholar138. Davis M, Redmond DE |r. Baratón |M: Noradrenergic agonists and antagonists effects on conditioned fear as measured by the potentiated startle paradigm, 1979; 65:111-118. Google Scholar139. Browne RG: Anxiolytics antagonize yohimbine's discriminative stimulus properties. Psychopharmacology 1981: 74:245-249. Google Scholar140. Hulmberg G. Gershon S: Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia 1961; 2:95-106. Google Scholar141. Myrgoiis R, Prieto P. Stein L. el al: Statistical summary of HH)OO male cases using alrodex in treatment of impotence. L'urr Titer Res 1971; 15:616-622. Google Scholar142. Nashold BS Ir. Wilson WP. Slaughter G: The midbrain and pain, in Bonita /J ted): .Advances in Neurology. New York. Raven Press. J 974. pp 191-196. Google Scholar143. Heath RG: Depth recording and stimulation studies in patients, in Winter A (ed): The Surgical Control of Behavior. Springfield, Illinois. Charles C. Thomas Publishers. 1971. Google Scholar144. Gerhardt S. Prowse J. Liebman JM: Anxiolytic drugs selectively increase preferred duration of rewarding, brain stimulation in a shuttlebox test. Pharmacol Biochem Behav 1982; 16:795-799. Google Scholar145. Schenberg LC. Graeff FG: Role of the periaqueductal grey substance in the antianxiety action of benzodiazepines. Pharmacol Biochem Behav 1978: 9:287-295. Google Scholar146. Clarke A. EiIeSE: Effect s of ACTH. benzodiazepines and 5-HT antagonists on escape from periaqueductal grey stimulation in the ral. Prog Neuro-I'svchopharmacol Biol Psychiatry 1982; 6:27-55.' Google Scholar147. Mohler II. Pole P. Cumin R, et al: Nicotinamide is a brain constituent with benzodiazepine-like actions. Nature 1979; 278:565-565. Google Scholar148. Skolnick P. Marangos PJ. Goodwin FK. el al. Identification of inosine and hypoxanthine as endogenous inhibitors ot | ;H| diazepam binding in the central nervous system. Life Sci 1978: 25:1475-1480. Google Scholar149. Sepinwall J. Cook L: Mechanism of action of the benzodiazepines: Behavioral aspect, led Proc 1980; 59( I2):5024-5051. Google Scholar150. MacDonald Il , Barker |L. Paul SM. el al: lnosine may be an endogenous ligand lor benzodiazepine receptor on cultured spinai neurona. Science 1979; 205:715-717. Google Scholar151. Woolf IH. Nixon |C: Endogenous effector of the benzodiazepine binding site: Purification and characterization. Biochemistry 1981; 20:4265-4269. Google Scholar152. Massolli M. Guidoni A. Costa E: Characterization of benzodiazepine and ^-aminobutyric recognition siles and ibeir endogenous modulators. J Neurosa 1981; 1:409-418. Google Scholar153. Skolnick P. Lock K-L. Paugh B. et al: Pharmacologic and behavioral effects of EMD 28422: A novel purine which enhances |'H| diazepam binding to brain benzodiazepine receptors. Pharmacol Biochem Behav 1980. 12:685-689. Google Scholar154. Lehman HE: Tranquilizers: Clinical insufficiencies and needs; quoted in Future prospects of anxiolytic drugs, in Fielding S. LaI H (eds): Industrial Pharmacology'. Mount Kisco. New York. Futura Publishing, 1979. ? 405. vol 5. Google Scholar155. Lader M: Benzodiazepine dependence, in Murry R, el al (eds): The Misuse of Psychotropic Drugs. (Royal College of Psychiatrists Special Publication No. L). London. Gaskell Press. 1981. Google Scholar Previous article Next article FiguresReferencesRelatedDetails Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download • 17.5 MB Published online3/01/87
Referência(s)